Matsuda Masaru

See Remarks

Matsuda Masaru has filed 10 SEC Form 4 filings (20 transaction rows) across 1 company, with disclosures dating back to 2025. 9 of those filings fall inside the rolling window. Most recent filing: Sep 18, 2026.

On the most recent filing, Matsuda Masaru is listed as See Remarks at Arcutis Biotherapeutics, Inc. Inside the rolling window, Matsuda Masaru reported no open-market purchases and 10 open-market sales totaling $2.2M in ARQT. The largest disclosed transaction in the window is a sale of 40,638 ARQT shares on Feb 2, 2026, worth $1.0M.

Companies traded

Other insiders at ARQT

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$2.2M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
ARQTSale$92KSep 18SEC ↗
ARQTSale$250KSep 10SEC ↗
ARQTSale$32KAug 6SEC ↗
ARQTSale$192KMay 6SEC ↗
ARQTSale$93KMar 3SEC ↗
ARQTSale$221KMar 3SEC ↗
ARQTSale$1.0MFeb 4SEC ↗
ARQTSale$50KDec 3SEC ↗
ARQTSale$72KNov 21SEC ↗
ARQTSale$178KNov 5SEC ↗
Showing 1–10 of 10
1 / 1

Earlier trades

Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.

DateTickerTypeValue
Sep 4, 2025ARQTSale$584K
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Matsuda Masaru made?

Matsuda Masaru has filed 10 SEC Form 4 filings (20 transaction rows) across 1 company since 2025.

Which companies does Matsuda Masaru trade?

Matsuda Masaru has filed SEC Form 4 disclosures for 1 company, including ARQT.

When was Matsuda Masaru's most recent SEC Form 4 filing?

Matsuda Masaru's most recent SEC Form 4 filing on Tracefour is dated Sep 18, 2026.

What is Matsuda Masaru's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Matsuda Masaru is listed as See Remarks.

What is Matsuda Masaru's total buy and sell value in the current window?

Inside the rolling retention window, Matsuda Masaru bought $0 and sold $2.2M based on SEC Form 4 filings.

What was Matsuda Masaru's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 40,638 ARQT shares on 2026-02-02, worth $1.0M, per SEC Form 4 filings.